Studies on Lymphangiogenesis Inhibitors from Korean and Japanese Crude Drugs
Access this Article
Search this Article
Metastasis occurs when cancer cells detach from a tumor, travel to distant sites in the body and develop into tumors in these new locations. Most cancer patients die from metastases. Among the various forms of cancer metastasis, lymphatic metastasis is an important determinant in cancer treatment and staging. In this study, we investigated lymphangiogenesis inhibitors from crude drugs used in Japan and Korea. The three crude drugs Saussureae Radix, Psoraleae Semen and Aurantti Fructus Immaturus significantly inhibited the proliferation of temperature-sensitive rat lymphatic endothelial (TR-LE) cells <i>in vitro</i>. By a chromatographic method using bioassay-guided fractionation methods, costunolide (<b>1</b>) and dehydrocostus lactone (<b>2</b>) from S. Radix, <i>p</i>-hydroxybenzaldehyde (<b>3</b>), psoralen (<b>4</b>), angelicin (<b>5</b>), psoracorylifol D (<b>6</b>), isobavachalone (<b>7</b>), bavachinin (<b>8</b>) Δ<sup>3</sup>,2-hydroxybakuchiol (<b>9</b>) and bakuchiol (<b>10</b>) from P. Semen and <i>cis</i>-octadecyl ferulate (<b>11</b>), (2<i>R</i>)-3β,7,4′-trihydroxy-5-methoxy-8-(γ,γ-dimethylallyl)-flavanone (<b>12</b>), (2<i>S</i>)-7,4′-dihydroxy-5-methoxy-8-(γ,γ-dimethylallyl)-flavanone (<b>13</b>) and umbelliferone (<b>14</b>) from A. F. Immaturus were obtained. Three compounds (compounds <b>11</b>–<b>13</b>) from A. F. Immaturus were isolated for the first time from this medicinal plant. Among isolated compounds, ten compounds (compounds <b>1</b>, <b>2</b>, <b>6</b>–<b>12</b>, <b>13</b>) showed an inhibitory effect on the proliferation and the capillary-like tube formation of TR-LE cells. In addition, all compounds except compound <b>12</b> showed selective inhibition of the proliferation of TR-LE cells compared to Hela and Lewis lung carcinoma (LLC) cells. These compounds might offer clinical benefits as lymphangiogenesis inhibitors and may be good candidates for novel anti-cancer and anti-metastatic agents.
- Biological and Pharmaceutical Bulletin
Biological and Pharmaceutical Bulletin 36(1), 152-157, 2013
The Pharmaceutical Society of Japan